$UTHR
SEC EDGAR Filings Hub
2 Filings
$UTHR · UNITED THERAPEUTICS Corp SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for UNITED THERAPEUTICS Corp ($UTHR) from November 4, 2026 through November 4, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $UTHR portfolio concentration →
View $UTHR Congress trades →
Research $UTHR stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports1
8-K Material Events1
Form 4 Insider0
High-Impact0
Latest FilingNovember 4, 2026
Browse SEC Filings by Form Type
Latest $UTHR SEC Filings & AI Summaries (2)
November 4, 2026
$UTHR 10-Q — UNITED THERAPEUTICS Corp
A rare quarter where revenue growth and aggressive buybacks coexist with a 20% EPS decline from surging R&D investment.
November 4, 2026
$UTHR 8-K — UNITED THERAPEUTICS Corp
Record revenue and a fresh $2B buyback contrast with a 24% profit drop from a one-time acquisition charge, leaving investors to weigh pipeline investment against near-term earni…
Related & Peer Company SEC Filing Hubs